| [1] |
Kemper MJ, Meyer-Jark T, Lilova M, et al.Combined T-and B-ccll activation in childhood steroid-sensitive nephrotic syndrome [J]. Clin Nephrol, 2003, 60(4): 242-247.
|
| [2] |
Sinha A, Bagga A. Rituximab therapy in nephrotic syndrome: implications for patients′ management [J]. Nat Rev Nephrol, 2013, 9(3): 154-169.
|
| [3] |
Ito S, Kamei K, Ogura M, et al. Survey of rituximab treatment for childhood-onset refractory nephritic syndrome [J]. Pediatr Nephrol, 2013, 28 (2): 257-264.
|
| [4] |
Gulati A, Sinha A, Jordan SC, et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and-dependent nephrotic syndrome: multicentric report [J]. Clin J Am Soc Nephrol, 2010, 5(12): 2207-2212.
|
| [5] |
Prytula A, Iijima K, Kamei K, et al. Rituximab in refractory nephrotic syndrome [J]. Pediatr Nephrol, 2010, 25(3): 461-468.
|
| [6] |
Fernandez FG, Segarra A, Gonzalez E, et al. Rituximab treatment of adult patients with steroid -resistant focal segmental glomerulosclerosis [J] . Clin J Am Soc Nephrol, 2009，4(8): 1317-1323.
|
| [7] |
Bomback AS, Derebail VK, McGregor JG, et al. Rituximab therapy for membranous nephropathy: a systematic review [J]. Clin J Am Soc Nephrol, 2009, 4(4): 734-744.
|
| [8] |
Mallat SG, Itani HS, Abou-Mrad RM. Rituximab use in adult primary glomerulopathy: where is the evidence? [J]. Ther Clin Risk Manag, 2016, 29(12): 1317-1327.
|
| [9] |
Trachtman H, Fervenza FC, Gipson DS, et al. A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis [J]. Kidney Int, 2011, 79(11): 1236-1243.
|
| [10] |
Ashraf S, Gee HY, Woerner S, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption [J]. J Clin Invest, 2013, 123(12): 5179-5189.
|
| [11] |
Korkmaz E, Lipska-Ziętkiewicz BS, Boyer O, et al. ADCK4-associated glomerulopathy causes adolescence-onset FSGS [J]. J Am Soc Nephrol, 2016, 27(1): 63-68.
|
| [12] |
Muso E, Mune M, Hirano T, et al. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study [J]. Clin Exp Nephrol, 2015, 19(3): 379-386.
|
| [13] |
Saleem MA. New developments in steroid-resistant nephrotic syndrome [J]. Pediatr Nephrol, 2013, 28(5): 699-709.
|
| [14] |
Hogan J, Mohan P, Gerald B. Diagnostic tests and treatment options in glomerular disease: 2014 update [J]. Am J Kidney Dis, 2014, 63 (4): 656-666.
|
| [15] |
高燕翔，张佩青，张琪．张琪教授以"通"为用治疗难治性肾病综合征水肿经验[J]．中国中西医结合肾病杂志，2014，15(8): 48-49.
|
| [16] |
孟立锋，史伟，吴金玉，等．湿热病邪与难治肾病综合征关系探讨[J]．江苏中医药杂志，2013，45(10): 11-13.
|